SCHEMBL5585932

SCHEMBL5585932

CCCc1ccc(-c2oc(CBr)nc2Br)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NISCH Q9Y2I1 1/20 0.35
GFER P55789 1/20 0.34
PPARD Q03181 2/20 0.34
S1PR1 P21453 4/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
POLB P06746 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
LPL P06858 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14384248 0.72 PPARD (0.60) PPARD
SCHEMBL5585973 0.71 NOTUM (0.43) MAPTNPC1RAB9ASMN1; SMN2NISCH
SCHEMBL4608185 0.71 SCN5A (0.40) MAPTNPC1RAB9ASMN1; SMN2NISCH
SCHEMBL27217117 0.69 NR4A2 (0.41) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL2219797 0.68 HRH3 (0.45) MAPTNPC1RAB9AALDH1A1HSD17B10
SCHEMBL5524819 0.67 PTGS2 (0.35) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL5726725 0.66 LPL (0.50) ALDH1A1KDM4ENISCHPOLBCTDSP1
SCHEMBL4802707 0.65 LPL (0.54) MAPTNPC1RAB9AHSD17B10NISCH
SCHEMBL21887379 0.65 NISCH (0.47) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL10655296 0.65 TDP1 (0.48) MAPTNPC1RAB9AHSD17B10NISCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070244130-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2007-10-18 US disclosed
US-20070244130-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2007-10-18 US disclosed
US-20070244130-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2007-10-18 US disclosed
EP-1749003-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-02-07 EP disclosed
WO-2005116016-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2005-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244130-A1 Compounds and Compositions as Ppar Modulators PPARG, PPARA, PPARD MAPT 3464/4885NPC1 425/4885RAB9A 2891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.